ARCHIVES

NCI Agrees To give NSABP One Year Until Competition; Advisors OK Concept

This article is from The Cancer Letter archive.

Vol. 20 No. 24 | June 17, 1994

Download PDF Visit The Full Archive

Related Articles

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts

June 14, 2013

Harold Amos Receives Drew Medical Prize

October 27, 1989

NCI Research Plan Proposes Spending $5 Billion In FY2002.

November 3, 2000

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003

Diet & Nutrition, Carcinogenesis, Virus, Tobacco Committees Proposed For Elimination

May 6, 1977